Siemens to feature IT quality measures

Article

Siemens to feature IT quality measuresWood heads image analysis firm

Siemens to feature IT quality measures
Siemens will demonstrate on Oct. 4 how its Soarian Quality Measures product saves time and improves accuracy associated with chart abstraction, as well as prepares users for Medicare’s upcoming plans to increase the number of core quality measures. The presentation will be part of an educational breakout session at the American Health Information Management Association Convention and Exhibit in Grapevine, TX. The company will also feature Soarian Quality Measures in its booth among other information technology tools that offer plan-of-care functionality, enterprise document management, and state-of-the-art data mining and reporting.

Wood heads image analysis firm
Susan A. Wood, Ph.D., is the new president and CEO of VIDA Diagnostics, a developer of quantitative imaging software used in clinical research to analyze pulmonary diseases, including asthma and lung cancer, and chronic obstructive pulmonary disease. Wood succeeds John Garber, who helped build VIDA from an academic concept. Wood will focus on the continued development and commercialization of the company's FDA-cleared pulmonary applications, while transitioning quantitative pulmonary imaging into routine clinical practice. Wood joined VIDA's board last year. Previously she served as executive vice president of marketing and technology at Vital Images and led marketing and new product development at R2 Technology, now part of Hologic.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.